Monday, September 21, 2020 7:31:40 PM
Common Equity 6/30/2020. $16.5 billion
Deferred G-fees. $32.5 billion
SPS. $120.8 billion
Acc. Deficit. -$116.9 billion
Total common equity. $52.9 billion
Shares Outstanding. 1.16 billion
Equity per common share $45.6
2019 Earnings. $14.2 billion
Multiple 12
Corp value based on mult. $170.4 billion
Share Value based on mult. $146.9
Share Val. Mult. + Equity $192.5
Please let me know which of the above facts you dispute. Also please provide your justification for $5 valuation assuming law and order prevails.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM